# Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy

> **NCT00503568** · PHASE1 · COMPLETED · sponsor: **University of Miami** · enrollment: 19 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** Ad100-gp96Ig-HLA A1

## Key facts

- **NCT ID:** NCT00503568
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2016-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00503568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00503568, "Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00503568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*